Jiamin

Jianmin Pharmaceutical Group is a China-based publicly traded pharmaceutical company focused on pediatric medicines, women's health products, and distinctive traditional Chinese medicine products. The company markets commercial products including Longmu Zhuanggu Granules, Xiaoer Zibei Xuanfei Syrup, Qirui Weishu Capsules, Biantong Capsules, and Jianpi Shengxue Tablets, and it also operates consumer health and traditional Chinese medicine clinic businesses. Jianmin describes itself as a national pediatric drug production base and a key traditional Chinese medicine enterprise, with core brands including Jianmin and Longmu. Its pipeline includes multiple traditional Chinese medicine innovation programs, with products such as Xiaoer Zibei Xuanfei Syrup already approved and additional candidates such as Zhizhu Tongbian Granules and Tongjiang Granules in clinical development. Overall, the company is a commercial-stage Chinese medicine and pediatric healthcare player rather than a venture-stage biotech.